Last month Forbes reported that the cost of a single clinical trial can cost up to $100 million.
One can only imagine the cost of making a mistake somewhere along the way that would require starting again from scratch or, worse yet, making a mistake that prevents the drug from getting FDA approval and entering the market.
Forbes further acknowledged that saving money in drug development could end up causing the developer’s stock prices to increase significantly.
For these reasons it is essential that clinical trials are planned in an effective and efficient method from the very start of the process.
Here are 4 fundamental tips for planning an efficient yet high-quality clinical study from the biostatistics point of view:
Effective statistical planning from the very beginning can ensure passing the
regulatory expectations of the FDA and save money not only in the short-run but also in the long-run.
Address: 34 Jerusalem Rd.
Beit Gamla -Bldg B, 5th Floor,
Raanana, 4350108 Israel